CULLINAN THERAPEUTICS INC. - COMMON STOCK

Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors

02 نوفمبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 نوفمبر 2022 17:23:46 بحسب Nasdaq GlobeNewswire

Cullinan Oncology to Participate in Upcoming Investor Conferences

01 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Significantly Increases Ownership Stake in its MICA Subsidiary which Holds Worldwide Rights to Clinical-Stage Novel Monoclonal Antibody CLN-619

25 أكتوبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 أكتوبر 2022 16:50:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference

07 سبتمبر 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 سبتمبر 2022 17:27:22 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer

15 أغسطس 2022 16:57:42 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

10 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 أغسطس 2022 16:55:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology to Participate in William Blair Biotech Focus Conference

05 يوليو 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 يوليو 2022 16:38:19 بحسب Nasdaq GlobeNewswire

Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417

23 يونيو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 يونيو 2022 17:00:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting

31 مايو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting

26 مايو 2022 08:45:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference

19 مايو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Provides Corporate Update and Reports First Quarter 2022 Financial Results

16 مايو 2022 06:45:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl

12 مايو 2022 02:00:00 بحسب Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 مايو 2022 17:10:24 بحسب Nasdaq GlobeNewswire